Wegovy Savings Card: How to Get Wegovy for $0 or $25/Month

How the Wegovy Savings Card Works

The Wegovy savings program operates through Novo Nordisk's NovoCare patient support program. There are two distinct programs depending on your insurance status:

For commercially insured patients: The savings card can reduce your copay to as low as $0/month. Specifically, eligible patients pay a minimum of $0 and a maximum of $225/month, depending on their plan's coverage structure. Patients with good insurance coverage for Wegovy most frequently pay $0–25/month.

Eligibility requirements for insured patients:

• Must have commercial insurance (employer-sponsored, individual market, ACA marketplace)
• Disqualifying: Medicare, Medicaid, CHIP, TRICARE, or other federal/state government insurance
• Wegovy must be covered by your specific insurance plan (or have a path to coverage via prior authorization)
• No income maximum for the commercial savings program

For uninsured patients: The Wegovy WeightCare program offers a different pathway at $499/month — significantly below the list price of $1,349/month, but substantially more than the insured program.

Step-by-Step: Getting the Savings Card

1. Get a prescription: You need a valid Wegovy prescription from a licensed prescriber. Wegovy is approved for adults with BMI ≥30, or ≥27 with at least one weight-related condition (hypertension, type 2 diabetes, high cholesterol).

2. Activate the savings card: Go to WegovyPro.com or the Novo Nordisk NovoCare portal. Alternatively, your prescriber's office or pharmacy can help with enrollment.

3. Present at pharmacy: Show the savings card along with your prescription at the pharmacy. The discount is applied at point of sale.

4. Annual renewal: The savings program requires annual re-enrollment. If your insurance changes, your savings card eligibility may change.

Why Insurance Coverage Is the Key Variable

The savings card reduces your out-of-pocket cost, but it doesn't create coverage where none exists. If your insurance plan doesn't cover Wegovy at all, the card applies to list price — which is $1,349/month — and reduces it to the uninsured rate ($499/month), not to $0–25.

Getting Wegovy to $0–25/month requires your insurance plan to cover it (with the savings card then reducing the copay). This makes insurance coverage the make-or-break factor, not just the savings card.

How to get your insurance to cover Wegovy:

• Prior authorization: Most plans require PA for Wegovy. Your prescriber submits documentation of BMI, related conditions, and failed prior treatments.
• Appeals: If denied, appeal with clinical documentation. Many denials are overturned on appeal.
• Check formulary: Some plans cover Wegovy at a specific tier. Moving to a plan with Wegovy on formulary (during open enrollment) is worth considering for high-cost patients.

What If You Don't Qualify?

Medicare patients: Medicare Part D plans cannot cover Wegovy specifically for weight loss due to the Medicare Modernization Act exclusion on obesity drugs. The Treat and Reduce Obesity Act, if passed, would change this — but as of 2026, coverage remains unavailable for most Medicare beneficiaries without a qualifying diabetes diagnosis.

Medicaid patients: Coverage varies by state. A growing number of state Medicaid programs have added GLP-1 coverage for obesity, but access is not universal.

Uninsured patients at $499/month still expensive? Consider:

• Zepbound (tirzepatide) via LillyDirect: $399–549/month for FDA-approved tirzepatide vials directly from Eli Lilly, often with superior efficacy vs. semaglutide
• Ozempic savings card: If you have type 2 diabetes, Ozempic is often covered where Wegovy is not — same active ingredient (semaglutide), different approved indication
• Compounded options: See compounded semaglutide article for current legal/safety considerations

Ozempic vs. Wegovy Savings Cards

Both Ozempic and Wegovy contain semaglutide, but they are approved for different indications and have separate savings programs:

Ozempic savings card: For type 2 diabetes patients. Can reduce cost to as low as $25/month for eligible commercially insured patients. Ozempic has broader insurance coverage than Wegovy because diabetes drugs have fewer formulary restrictions than obesity medications.

Wegovy savings card: For obesity/weight loss patients. Same $0–225/month structure for commercially insured patients, but insurance coverage for Wegovy is less reliable than for Ozempic.

Some patients with both obesity and type 2 diabetes receive Ozempic instead of Wegovy because coverage is more consistent — the active medication is identical; the approved dose ceiling differs (1 mg for Ozempic vs. 2.4 mg for Wegovy).

Bottom Line

The Wegovy savings card can reduce out-of-pocket cost to $0–25/month, but only for patients whose commercial insurance covers Wegovy. The savings card itself doesn't create coverage — it reduces copays. Getting coverage often requires prior authorization and sometimes appeals. Medicare and Medicaid patients face separate (more limited) pathways. Uninsured patients have the $499/month uninsured rate or alternatives like Zepbound's LillyDirect program.

Sources

• Novo Nordisk, Wegovy WeightCare Program Information
• Wilding JPH et al., "Once-Weekly Semaglutide in Adults with Overweight or Obesity," NEJM, 2021
• KFF, "Coverage of Obesity Treatment: State of Medicaid and Medicare," 2024
• Novo Nordisk, NovoCare Patient Assistance Program